Vectorized Anti-Tnf-Alpha Inhibitors For Ocular Indications

Patent No. EP4518973 (titled "Vectorized Anti-Tnf-Alpha Inhibitors For Ocular Indications") was filed by Regenxbio on May 3, 2023. The application was issued on Mar 12, 2025.

Patent Summary

Patent Family

Patent Family

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4518973

REGENXBIO
Application Number
EP23730320A
Filing Date
May 3, 2023
Status
Request For Examination Was Made
Feb 7, 2025
Publication Date
Mar 12, 2025